Fig. 5From: Differences in oxylipin profile in psoriasis versus psoriatic arthritisOxylipin profile in PsA and PsO patients. A PLS-DA scores plot of PsA patients (N = 19) and PsO patients (N = 20). The explained variances for each component are shown in brackets. B Important features identified by PLS-DA. The colored boxes on the right indicate the relative concentrations of the corresponding metabolite in each group under study. C Heatmap performed using the important features identified by PLS-DABack to article page